Back
Madrigal Pharmaceuticals Stock Predictions
Today's Fastest Growing Company Might Surprise You
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
MDGL
Madrigal Pharmaceuticals
Last Price:
$314.08
Seasonality Move:
-6.73%
7 Day Trial
ALL ACCESS PASS
$
7
Hidden Stock Under $5 Holds Tech World Hostage
Click here to see more.Madrigal Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 30.3% based on the past 17 years of stock performance.
-
Madrigal Pharmaceuticals has risen higher in 7 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.18%
-
Is Madrigal Pharmaceuticals Stock Undervalued?The current Madrigal Pharmaceuticals [MDGL] share price is $308.57. The Score for MDGL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Madrigal Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 30.3% based on the past 17 years of stock performance.
Madrigal Pharmaceuticals Stock Rating
Sell
43
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals overpriced?
-
Madrigal Pharmaceuticals has risen higher in 7 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.18%
Madrigal Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
madrigalpharma.com
52-Week Data
52-Week High:
368.29
52-Week Low:
168.25
Prediction Charts
Market Cap:
6.7B
Price in USD:
308.57
Volume:
198.7K
Beta:
1.05
Technical Analysis
SMA50:
300.58
SMA100:
266.63
SMA200:
258.83
52-Wk Change:
33.36%
Stock Predictions
-
Is Madrigal Pharmaceuticals stock public?Yes, Madrigal Pharmaceuticals is a publicly traded company.
-
What is the Madrigal Pharmaceuticals stock quote today?The Madrigal Pharmaceuticals stock price is 308.57 USD today.
-
How to buy Madrigal Pharmaceuticals stock online?You can buy Madrigal Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-11 | 315.87 | 306.55 | 315.87 | 306.00 |
| Dec-12 | 306.21 | 302.47 | 311.77 | 302.47 |
| Dec-13 | 301.12 | 304.50 | 308.65 | 295.02 |
| Dec-16 | 305.94 | 310.99 | 312.28 | 301.93 |
| Dec-17 | 306.38 | 306.08 | 315.09 | 305.00 |
| Dec-18 | 306.30 | 293.11 | 310.00 | 289.80 |
| Dec-19 | 295.00 | 293.41 | 300.25 | 290.80 |
| Dec-20 | 294.00 | 308.71 | 312.52 | 293.00 |
| Dec-23 | 310.81 | 310.87 | 311.18 | 302.16 |
| Dec-24 | 310.55 | 312.00 | 313.96 | 307.74 |
| Dec-26 | 310.17 | 314.04 | 314.64 | 308.63 |
| Dec-27 | 310.00 | 313.11 | 317.67 | 308.12 |
| Dec-30 | 308.73 | 311.62 | 315.28 | 306.02 |
| Dec-31 | 316.27 | 308.57 | 316.98 | 305.02 |
Madrigal Pharmaceuticals Earnings
Madrigal Pharmaceuticals Earnings Report: Per Share Madrigal Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Madrigal Pharmaceuticals Forecast Revenue Growth
Madrigal Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Madrigal Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $4.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.27 per share, and an increase next year of $15.85 per share.
* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.